Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IRDye800CW-BBN PET-NIRF in Lower Grade Glioma

NCT03407781 is registered in ClinicalTrials.gov with Deling Li as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03407781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IRDye800CW-BBN PET-NIRF in Lower Grade Glioma
Lead sponsor
Deling Li
Phase
Phase 1
Overall status
Completed
Start date
January 1, 2016
Completion date
August 17, 2018
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.